Hexagen

August 21, 1998

Hexagen, a biotechnology company that grew out of the University of Cambridge two years ago, has been taken over by Incyte Pharmaceuticals of the United States for Pounds 23.5 million.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments